Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Our tasks regarding COVID-19

Read about the tasks of the pharmaceutical authorities regarding the approval of a vaccine against COVID-19 as well as the supply of medicines and medical devices in general.

Go to theme

News and notifications

Dexamethasone can be used for the treatment of certain COVID-19 patients

25 September 2020

Dexamethasone can be used for the treatment of hospitalised COVID-19 patients requiring supplemental oxygen. This has been confirmed by the European Medicines Agency (EMA) after a review of the results from the so-called RECOVERY study on the use of dexamethasone in the treatment of COVID-19.

Second contract ensures access to a potential vaccine for COVID-19

25 September 2020

Denmark and EU part of an international vaccine alliance to ensure COVID-19 vaccines for low- and middle-income countries

25 September 2020

Final report on market dialogue regarding the acquisition of a future pharmacovigilance system

24 September 2020